N. Akiyama

Pilot study for preoperative administration of l-OHP to patients with advanced scirrhous type gastric cancer.

H. Yanagie, M. Eriguchi, G. Mathé, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Surgery in patients with HIV infection: indications and outcome.

H. Yanagie, M. Eriguchi, Y. Fujii, 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A HUGE MALIGNANT PHYLLODE TUMOR OF THE BREAST IN WHICH THE TUMOR PENERTRATED THE SKIN TO BE EXPOSED : A CASE REPORT

H. Yanagie, M. Eriguchi, I. Yoshizaki, 1996 .

Orally Active DACH-Pt (IV) Compounds

M. Eriguchi, R. Kizu, A. Matsuzawa, 1996 .

A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV)

K. Hayakawa, T. Nakanishi, M. Eriguchi, 1999, Cancer Chemotherapy and Pharmacology.

Regional lymph node metastasis of early gastric cancer.

H. Yanagie, M. Eriguchi, H. Shimizu, 1991, The European journal of surgery = Acta chirurgica.

Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.

M. Eriguchi, R. Kizu, Y. Takeda, 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

An orally active antitumor cyclohexanediamine‐Pt(IV) complex: trans,cis,cis‐bis(n‐valerato) (oxalato)(1R,2R‐cyclohexanediamine)Pt(IV)

T. Nakanishi, M. Eriguchi, T. Tashiro, 1996, Anti-cancer drugs.

Significance of water solubility in the gastrointestinal absorption of trans‐bis(n‐valerato)(1 R,2R‐cyclohexanediamine)(oxalato)platinum(IV), an orally active antitumor platinum complex, and its analogs

K. Hayakawa, T. Nakanishi, M. Eriguchi, 1998, Anti-cancer drugs.